Detection of the origin of atrial tachycardia by 3D electro-anatomical mapping and treatment by radiofrequency catheter ablation in horses.


Journal

Journal of veterinary internal medicine
ISSN: 1939-1676
Titre abrégé: J Vet Intern Med
Pays: United States
ID NLM: 8708660

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 14 10 2021
accepted: 27 05 2022
pubmed: 11 6 2022
medline: 27 7 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

Atrial tachycardia (AT) can be treated by medical or electrical cardioversion but the recurrence rate is high. Three-dimensional electro-anatomical mapping, recently described in horses, might be used to map AT to identify a focal source or reentry mechanism and to guide treatment by radiofrequency ablation. To describe the feasibility of 3D electro-anatomical mapping and radiofrequency catheter ablation to characterize and treat sustained AT in horses. Nine horses with sustained AT. Records from horses with sustained AT referred for radiofrequency ablation at Ghent University were reviewed. The AT was drug resistant in 4 out of 9 horses. In 8 out of 9 horses, AT originated from a localized macro-reentrant circuit (n = 5) or a focal source (n = 3) located at the transition between the right atrium and the caudal vena cava. In these 8 horses, local radiofrequency catheter ablation resulted in the termination of AT. At follow-up, 6 out of 8 horses remained free of recurrence. Differentiation between focal and macro-reentrant AT in horses is possible using 3D electro-anatomical mapping. In this study, the source of right atrial AT in horses was safely treated by radiofrequency catheter ablation.

Sections du résumé

BACKGROUND BACKGROUND
Atrial tachycardia (AT) can be treated by medical or electrical cardioversion but the recurrence rate is high. Three-dimensional electro-anatomical mapping, recently described in horses, might be used to map AT to identify a focal source or reentry mechanism and to guide treatment by radiofrequency ablation.
OBJECTIVES OBJECTIVE
To describe the feasibility of 3D electro-anatomical mapping and radiofrequency catheter ablation to characterize and treat sustained AT in horses.
ANIMALS METHODS
Nine horses with sustained AT.
METHODS METHODS
Records from horses with sustained AT referred for radiofrequency ablation at Ghent University were reviewed.
RESULTS RESULTS
The AT was drug resistant in 4 out of 9 horses. In 8 out of 9 horses, AT originated from a localized macro-reentrant circuit (n = 5) or a focal source (n = 3) located at the transition between the right atrium and the caudal vena cava. In these 8 horses, local radiofrequency catheter ablation resulted in the termination of AT. At follow-up, 6 out of 8 horses remained free of recurrence.
CONCLUSIONS AND CLINICAL IMPORTANCE CONCLUSIONS
Differentiation between focal and macro-reentrant AT in horses is possible using 3D electro-anatomical mapping. In this study, the source of right atrial AT in horses was safely treated by radiofrequency catheter ablation.

Identifiants

pubmed: 35686355
doi: 10.1111/jvim.16473
pmc: PMC9308432
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1481-1490

Subventions

Organisme : Bijzonder Onderzoeksfonds
ID : BOF.BAS.2018.0022.01
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 1S56217N

Informations de copyright

© 2022 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.

Références

J Cardiovasc Electrophysiol. 2010 Jul;21(7):760-5
pubmed: 20132385
Europace. 2017 Mar 1;19(3):465-511
pubmed: 27856540
J Vet Emerg Crit Care (San Antonio). 2017 May;27(3):362-368
pubmed: 28267896
Heart Rhythm. 2009 Dec;6(12):1699-705
pubmed: 19959115
Heart Rhythm. 2005 Jun;2(6):578-91
pubmed: 15922263
J Cardiovasc Electrophysiol. 2009 Jun;20(6):706-9; quiz 705
pubmed: 19490271
J Cardiovasc Electrophysiol. 2009 May;20(5):480-91
pubmed: 19207747
J Cardiovasc Electrophysiol. 2020 May;31(5):1211-1212
pubmed: 32108401
Pacing Clin Electrophysiol. 2011 Apr;34(4):414-21
pubmed: 21091746
J Vet Intern Med. 2014 May-Jun;28(3):749-61
pubmed: 24628586
Cardiol Young. 2015 Oct;25(7):1385-6
pubmed: 25613639
Vet J. 2020 Apr;258:105452
pubmed: 32564870
Vet J. 2008 Aug;177(2):198-204
pubmed: 17920965
Europace. 2017 May 01;19(5):775-783
pubmed: 27247002
J Am Coll Cardiol. 2012 Jan 10;59(2):143-9
pubmed: 22222078
J Vet Intern Med. 2022 Mar;36(2):758-769
pubmed: 35246994
J Vet Intern Med. 2021 Jan;35(1):521-531
pubmed: 33274799
J Vet Intern Med. 2010 May-Jun;24(3):539-45
pubmed: 20384960
J Cardiovasc Electrophysiol. 2002 Dec;13(12):1292-5
pubmed: 12521348
Anat Histol Embryol. 2018 Apr;47(2):145-152
pubmed: 29314148
Equine Vet J. 2020 Sep;52(5):765-772
pubmed: 31954064
J Vet Intern Med. 2008 Jul-Aug;22(4):915-23
pubmed: 18564226
Vet Rec. 1998 Mar 21;142(12):301-3
pubmed: 9569496
Equine Vet J. 2019 Sep;51(5):634-640
pubmed: 30648752
Vet J. 2020 Sep;263:105519
pubmed: 32928488
J Cardiovasc Electrophysiol. 2012 Feb;23(2):137-44
pubmed: 21955215
J Vet Cardiol. 2014 Mar;16(1):9-17
pubmed: 24461642
Equine Vet J. 2021 Jan;53(1):186-193
pubmed: 32285961
Eur Heart J. 2001 Jul;22(14):1162-82
pubmed: 11440490
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Eur Heart J. 2020 Feb 1;41(5):655-720
pubmed: 31504425
Circulation. 2002 Sep 10;106(11):1317-20
pubmed: 12221046
J Vet Intern Med. 2020 Nov;34(6):2701-2709
pubmed: 33098342
J Am Coll Cardiol. 2006 Sep 5;48(5):1010-7
pubmed: 16949495
Heart Rhythm. 2013 Apr;10(4):469-76
pubmed: 23266406
J Vet Emerg Crit Care (San Antonio). 2014 Nov-Dec;24(6):759-63
pubmed: 25388866
J Vet Intern Med. 2022 Jul;36(4):1481-1490
pubmed: 35686355
Vet Clin North Am Equine Pract. 2019 Apr;35(1):85-102
pubmed: 30871832
Heart Vessels. 2019 May;34(5):801-808
pubmed: 30456724
Vet J. 2013 Sep;197(3):583-8
pubmed: 23823082
Arrhythm Electrophysiol Rev. 2017 Jun;6(2):55-62
pubmed: 28835836

Auteurs

Glenn Van Steenkiste (G)

Equine Cardioteam Ghent University, Department of Large Animal Internal Medicine, Ghent University, Merelbeke, Belgium.

Tim Boussy (T)

Department of Cardiology, AZ Groeninge, Kortrijk, Belgium.

Mattias Duytschaever (M)

Department of Cardiology, AZ Sint-Jan, Bruges, Belgium.

Ingrid Vernemmen (I)

Equine Cardioteam Ghent University, Department of Large Animal Internal Medicine, Ghent University, Merelbeke, Belgium.

Stijn Schauvlieghe (S)

Department of Surgery and Anaesthesiology of Domestic Animals, Ghent University, Merelbeke, Belgium.

Annelies Decloedt (A)

Equine Cardioteam Ghent University, Department of Large Animal Internal Medicine, Ghent University, Merelbeke, Belgium.

Gunther van Loon (G)

Equine Cardioteam Ghent University, Department of Large Animal Internal Medicine, Ghent University, Merelbeke, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH